Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1123214

CCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC.[Cl-]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.96
HTT P42858 2/20 0.58
DNM1 Q05193 10/20 0.56
HSP90AA1 P07900 2/20 0.48
RAD52 P43351 2/20 0.48
PLA2G1B P04054 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
KMT2A Q03164 1/20 0.48
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2940953 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL1333871 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL1334492 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL10580170 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL1043094 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL23754402 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL10581679 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL10579988 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL319796 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52
Hydrochloric Acid SCHEMBL33447 1.00 LMNA (0.96) LMNAHTTDNM1HSP90AA1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122076677-A Antibacterial composite coating based on quaternized nano zinc oxide and preparation method and application thereof 2026-05-26 CN claimed
CN-121574280-A Preparation process of carboxymethyl chitosan with high substitution degree 青岛博益特生物材料股份有限公司 2026-02-27 CN claimed
CN-119842241-A Zirconium-organic-phosphate-modified asphalt and preparation method thereof 北京工业大学 2025-04-18 CN claimed
CN-119804343-A High-sensitivity micron liquid crystal sensor for detecting propanol gas and preparation method thereof 江南大学 2025-04-11 CN claimed
CN-119286285-A Method for modifying surface of carbon nano tube 常州国重新材料科技有限公司 2025-01-10 CN claimed
CN-116178821-B Antibacterial fresh-keeping composite film and preparation method thereof 福建立邦包装有限公司 2024-05-03 CN claimed
CN-115845154-B Composition of nano antibacterial material and anticoagulation component and plasma preparation method thereof 中国科学院深圳先进技术研究院 2024-03-19 CN claimed
CN-116285600-B Preparation method of broad-spectrum intelligent antibacterial coating on surface of buried metal 西安理工大学 2024-01-19 CN claimed
CN-113529417-B Water-based organic silicon permeable anti-corrosion impregnant and preparation method thereof 中交上海三航科学研究院有限公司 2023-06-30 CN claimed
CN-116285600-A Preparation method of broad-spectrum intelligent antibacterial coating on surface of buried metal 西安理工大学 2023-06-23 CN claimed
US-20110143147-A1 Agent for providing substrates based on cellulose and/or starch with water repellent and simultaneously antifungal, antibacterial insect-repellent and antialgal properties DEGUSSA GMBH (DE) 2011-06-16 US claimed
WO-2007061625-A2 A THERAPEUTIC COMPOSITION CONTAINING AN ORGANOSILANE QUATERNARY COMPOUND AND HYDROGEN PEROXIDE FOR TREATING SKIN DISORDERS RESOURCE DEVELOPMENT L.L.C. (US) 2007-05-31 WO claimed
EP-1787650-A2 A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders Resource Development L.L.C. (US) 2007-05-23 EP claimed
EP-1773918-A1 AGENT FOR PROVIDING SUBSTRATES BASED ON CELLULOSE AND/OR STARCH WITH WATER-REPELLENT AND SIMULTANEOUSLY ANTIFUNGAL, ANTIBACTERIAL, INSECT-REPELLENT AND ANTIALGAL PROPERTIES Degussa GmbH (DE) 2007-04-18 EP claimed
US-20060110348-A1 Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using RESOURCE DEVELOPMENT L.L.C. 2006-05-25 US claimed
WO-2006010667-A1 AGENT FOR PROVIDING SUBSTRATES BASED ON CELLULOSE AND/OR STARCH WITH WATER-REPELLENT AND SIMULTANEOUSLY ANTIFUNGAL, ANTIBACTERIAL, INSECT-REPELLENT AND ANTIALGAL PROPERTIES DEGUSSA AG (DE) 2006-02-02 WO claimed
US-5885951-A CHELATING AGENT CONSISTING OF ETHYLENEDIAMINETETRAACETIC ACIDS, DIETHYLENETRIAMINEPENTAACETIC ACIDS, NITRILOTRIACETIC ACIDS, AND N-HYDROXYETHYLENEDIAMINETRIACETIC ACIDS, SOLVENT, NONIONIC SURFACTANT, MICROBIOCIDE Panich, Martin (US) 1999-03-23 US claimed
EP-0586384-A1 ORAL AND PERSONAL HYGIENE ARTICLES CONTAINING ACTIVE AGENTS BONDED TO THE SURFACE THEREOF WARNER-LAMBERT COMPANY (US) 1994-03-16 EP claimed
WO-1992015198-A1 ORAL AND PERSONAL HYGIENE ARTICLES CONTAINING ACTIVE AGENTS BONDED TO THE SURFACE THEREOF WARNER-LAMBERT COMPANY (US) 1992-09-17 WO claimed
US-5120325-A Color-matched sterile adhesive bandages containing melanin-like pigment composition FLESHTONES PRODUCTS CO., INC. (US) 1992-06-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060110348-A1 Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using CUTA, MPO, CAT LMNA 4694/4885HTT 866/4885DNM1 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.